Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition containing cassia seed for reducing blood fat

A cassia seed and composition technology, which is applied in the directions of drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of high price, unclear curative effect, and unfavorable promotion and price application.

Inactive Publication Date: 2015-03-11
CHENGDU GUORUI PHARMA TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many Chinese patent medicines for the treatment of hyperlipidemia, some of which have too large prescriptions and unclear curative effects, and some are quite expensive due to the use of precious medicinal materials in the prescriptions
These make it unfavorable to promote the price application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The blood lipid-lowering pharmaceutical composition described in the present embodiment is made of the following raw materials:

[0033] Astragalus 25g, cassia seed 8g, gynostemma 5g, propolis 6g, gastrodia elata 6g, calcium fruit leaf 6g, aloe vera 6g and licorice 3g.

[0034] The above-mentioned raw materials are prepared into granules, and the preparation method is as follows:

[0035] Add 9 times the volume of 60% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each Mix the liquid evenly, dry, then add 200g sucrose, make granules according to the preparation technology of granules, and pack into bags.

Embodiment 2

[0037] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0038] Astragalus 10g, cassia seed 15g, gynostemma 10g, propolis 3g, gastrodia elata 3g, calcium fruit leaf 12g, aloe vera 10g and licorice 2g.

[0039] The above-mentioned raw materials are prepared into tablets, and the preparation method is as follows:

[0040] Add 9 times the volume of 70% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each The mixture is uniformly mixed, dried, then mixed with 150 g of starch and 20 g of povidone, and prepared into a pharmaceutical composition of tablets by using existing tablet compression technology.

Embodiment 3

[0042] The blood lipid-lowering pharmaceutical composition described in this embodiment is made of the following raw materials:

[0043] Astragalus 35g, cassia seed 2g, gynostemma 2g, propolis 10g, gastrodia elata 10g, calcium fruit leaf 4g, aloe vera 2g and licorice 8g.

[0044] Above-mentioned raw material is prepared into powder, and preparation method is as follows:

[0045] Add 10 times the volume of 65% ethanol to the raw materials in the above weight ratio, reflux extraction three times, the extraction time is 2.0h, 1.5h, 1.5h respectively, filter, combine the filtrates for 3 times, recover the ethanol and concentrate, and then concentrate each Liquid mixed evenly, dried, then mixed with 180g dextrin, made into powder according to the preparation technology of powder, and packed into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition containing cassia seed for reducing blood fat. The pharmaceutical composition is composed of the following raw materials: radix astragali, cassia seed, gynostemma pentaphylla, propolis, rhizoma gastrodiae, prunus humilis bunge leaf, aloe, and licorice. Through the verification of pharmacological experiments, people find that the provided pharmaceutical composition has the advantages of good blood fat reducing effect, definite curative effect, and low dosage, no side or toxic effect to human body. Moreover, the formula is simple, and thus the pharmaceutical composition is easy to promote and use.

Description

technical field [0001] The invention relates to a medicine composition for lowering blood fat, in particular to a medicine composition made from astragalus, cassia seed, gynostemma pentaphyllum, propolis, gastrodia elata, calcifera leaves, aloe vera and licorice. Background technique [0002] With the continuous improvement of people's living standards, the incidence of hyperlipidemia is on the rise, and hyperlipidemia is the cause of coronary atherosclerotic heart disease (coronary heart disease), arteriosclerosis, fatty liver, diabetes, obesity important factors of disease. Therefore, it is of great practical significance to find efficient and non-toxic blood lipid-lowering drugs. [0003] Lipoproteins refer to proteins combined with lipids, including very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). The lipid composition of different lipoproteins is mainly quantitative different, less qualitatively different. 80%...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P3/06A61K35/644
CPCA61K36/481A61K9/146A61K9/1623A61K9/2059A61K9/4825A61K35/644A61K36/424A61K36/482A61K36/484A61K36/736A61K36/886A61K36/896A61K36/8988A61K2236/333A61K2236/39A61K2300/00
Inventor 彭超骆均勇张玲
Owner CHENGDU GUORUI PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com